Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

BACKGROUND: We investigated whether early dynamic changes of circulating free (cfDNA) levels as well as the neutrophil to lymphocyte ratio (NLR) could predict nivolumab effectiveness in pretreated patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 45 patients receiving ni...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Adv Med Oncol
Главные авторы: Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469277/
https://ncbi.nlm.nih.gov/pubmed/31019571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919839928
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы